• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • All Features
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Overview
    • Buy Sell Zone
    • Financials
    • News
      All News Earnings Calls Corporate Announcements Research Reports
    • Reports
    • Technicals
      Technicals Share Price History Delivery
    • Shareholding
      Shareholding Monthly MF Holdings Bulk Block Deals Insider Trading & SAST
    • Deals
      Bulk Block Deals Insider Trading & SAST
    • Corporate Actions
      All Dividend Bonus Split Rights Board Meetings
    • Alerts (1)
    • About

    Jubilant Pharmova Ltd.

    NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
    | Strong Performer, Getting Expensive
    1071.8000 -6.50 (-0.60%)
    NSE Oct 15, 2025 14:32 PM
    33.64% Gain from 52W Low
    Volume: 345.7K
    High volume today
    • Share on Facebook
    • Tweet
    • Share on LinkedIn
    • Share via Whatsapp

    logo
    Jubilant Pharmova Ltd.
    10 Feb 2017
    1071.80
    -0.60%

    Jubilant Lifescience Ltd Q3FY17 results comment

    buy
    Results Update: Jubilant Pharmova Ltd.
    by HDFC Securities
    HDFC Securities
    Revenue grew by 5.82% to Rs. 1438.81 Cr in Q3FY17 when compared to the previous quarter. Also, it grew by 8.65% when compared with Q3FY16.
    Copy Link Share on Share on Share on Share on
    Alert  
    Jubilant Pharmova Ltd.'s price crossed below 50Day SMA today
    More from Jubilant Pharmova Ltd.
    Recommended
    Market trades higher, Bank of Maharashtra's Q2FY26 net profit grows 25.2% YoY
    Trendlyne Marketwatch | 15 Oct 2025, 02:24PM
    Rural India is spending more, but household incomes haven’t caught up
    The Baseline | 15 Oct 2025, 01:21PM
    Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
    | 30 May 2020
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    • All Features
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Midwest
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)